Sectors
CURX
Curanex Pharmaceuticals Inc
4.49
1 x 0.42
1 x 0.27
bid
ask
-
0.07
1.54%
09:53 AM
timesize
| Ytd | 1256.50% | |
| 1y | -19.82% |
4.49
day range
4.54
3.58
52 week range
183.60
| Open | 4.54 | Prev Close | 4.56 | Low | 4.49 | High | 4.54 | Mkt Cap | 7.04M |
| Vol | 1.22K | Avg Vol | 9.89K | EPS | -7.38 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.50 | 200-d Avg | 7.00 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 3.33M | ||
| Research and Development Expense | 2.59M | ||
| Selling, General and Administrative Expense | 731.84K | ||
| Operating Income | -3.33M | ||
| Net Income | -3.29M | ||
| Net Income Common Stock | -3.29M | ||
| Net Income Common Stock (USD) | -3.29M | ||
| Consolidated Income | -3.29M | ||
| Earnings per Basic Share | -2.40 | ||
| Earnings per Basic Share (USD) | -2.40 | ||
| Earnings per Diluted Share | -2.40 | ||
| Earning Before Interest & Taxes (EBIT) | -3.29M | ||
| Earning Before Interest & Taxes (USD) | -3.29M | ||
| Weighted Average Shares | 1.42M | ||
| Weighted Average Shares Diluted | 1.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.94M | ||
| Cash and Equivalents (USD) | 2.94M | ||
| Current Assets | 4.79M | ||
| Property, Plant & Equipment Net | 280.94K | ||
| Total Assets | 5.07M | ||
| Debt Current | 94.41K | ||
| Total Debt | 276.36K | ||
| Current Liabilities | 104.31K | ||
| Debt Non-Current | 181.95K | ||
| Total Liabilities | 286.25K | ||
| Accumulated Retained Earnings (Deficit) | -11.29M | ||
| Shareholders Equity | 4.79M | ||
| Shareholders Equity (USD) | 4.79M | ||
| Assets Non-Current | 280.94K | ||
| Total Debt (USD) | 276.36K | ||
| Liabilities Non-Current | 181.95K | ||
| Trade and Non-Trade Payables | 154.00 | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 36.64K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.08M | ||
| Net Cash Flow from Operations | -1.08M | ||